All sponsors

Oruka Therapeutics, Inc. $ORKA

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING2
READOUTS ≤12 MONTHS1
Open Oruka Therapeutics, Inc. on the live radar map → 📅 $ORKA readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
EVERLAST-A
NCT07090330
P2Active, not recruitingPlaque Psoriasis802026-03-25 (-5 mo)
EVERLAST-B
NCT07290569
P2Active, not recruitingPlaque Psoriasis1602026-10-21
ORKA-002
NCT07474792
P2Active, not recruitingPlaque Psoriasis1602027-10
ORKA-002
NCT07783542
P2RecruitingHidradenitis Suppurativa (HS)2002028-10
ORKA-002-213
NCT07933783
P2Enrolling by invitationPlaque Psoriasis1602029-07-01
ORKA-001
NCT07449702
P2RecruitingPlaque Psoriasis2402030-05